JP2022520232A5 - - Google Patents
Info
- Publication number
- JP2022520232A5 JP2022520232A5 JP2021546891A JP2021546891A JP2022520232A5 JP 2022520232 A5 JP2022520232 A5 JP 2022520232A5 JP 2021546891 A JP2021546891 A JP 2021546891A JP 2021546891 A JP2021546891 A JP 2021546891A JP 2022520232 A5 JP2022520232 A5 JP 2022520232A5
- Authority
- JP
- Japan
- Prior art keywords
- gene therapy
- therapy vector
- raav gene
- raav
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025007633A JP2025063228A (ja) | 2019-02-12 | 2025-01-20 | ダノン病の治療のための遺伝子療法ベクター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962804521P | 2019-02-12 | 2019-02-12 | |
| US62/804,521 | 2019-02-12 | ||
| US201962934928P | 2019-11-13 | 2019-11-13 | |
| US62/934,928 | 2019-11-13 | ||
| PCT/US2020/017987 WO2020167996A1 (en) | 2019-02-12 | 2020-02-12 | Gene therapy vectors for treatment of danon disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025007633A Division JP2025063228A (ja) | 2019-02-12 | 2025-01-20 | ダノン病の治療のための遺伝子療法ベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520232A JP2022520232A (ja) | 2022-03-29 |
| JP2022520232A5 true JP2022520232A5 (enExample) | 2023-02-21 |
Family
ID=72043957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546891A Pending JP2022520232A (ja) | 2019-02-12 | 2020-02-12 | ダノン病の治療のための遺伝子療法ベクター |
| JP2025007633A Pending JP2025063228A (ja) | 2019-02-12 | 2025-01-20 | ダノン病の治療のための遺伝子療法ベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025007633A Pending JP2025063228A (ja) | 2019-02-12 | 2025-01-20 | ダノン病の治療のための遺伝子療法ベクター |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220143215A1 (enExample) |
| EP (1) | EP3924371A4 (enExample) |
| JP (2) | JP2022520232A (enExample) |
| KR (1) | KR20210125999A (enExample) |
| CN (2) | CN120324641A (enExample) |
| AU (3) | AU2020221842A1 (enExample) |
| BR (1) | BR112021015751A2 (enExample) |
| CA (1) | CA3128514A1 (enExample) |
| IL (1) | IL285238A (enExample) |
| MX (1) | MX2021009696A (enExample) |
| SG (1) | SG11202107744SA (enExample) |
| WO (1) | WO2020167996A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102673203B1 (ko) | 2016-04-20 | 2024-06-10 | 센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. | Pklr의 유전자 발현 증강을 위한 조성물 및 방법 |
| AU2018352583B2 (en) | 2017-10-16 | 2025-04-17 | Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. | Lentiviral vectors for delivery of PKLR to treat Pyruvate Kinase Deficiency |
| US12539316B2 (en) | 2018-04-11 | 2026-02-03 | Spacecraft Seven, Llc | Compositions and methods for stem cell transplant |
| IL278213B2 (en) | 2018-04-27 | 2026-04-01 | Rocket Pharmaceuticals Ltd | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) |
| EP3820537A4 (en) * | 2018-07-12 | 2022-04-13 | Spacecraft Seven, LLC | GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE |
| IL280465B2 (en) | 2018-07-30 | 2025-03-01 | Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P | Methods for gene modification of hematopoietic cells |
| WO2022032226A1 (en) * | 2020-08-07 | 2022-02-10 | Spacecraft Seven, Llc | Plakophilin-2 (pkp2) gene therapy using aav vector |
| CN116887868A (zh) * | 2020-12-07 | 2023-10-13 | 太空飞船七有限责任公司 | 达农病的治疗 |
| CN114874990A (zh) * | 2021-02-05 | 2022-08-09 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种功能化外泌体及其制备方法和应用 |
| US12609410B2 (en) | 2021-09-23 | 2026-04-21 | Lg Energy Solution, Ltd. | High heat-resistant connector, and battery module, battery pack, and vehicle including the same |
| CN114457112A (zh) * | 2022-02-07 | 2022-05-10 | 苏州市立医院 | 一种特异性神经靶向mr分子探针及其制备方法和应用 |
| CN115975051B (zh) * | 2022-11-17 | 2025-09-12 | 东南大学 | 靶向外泌体及制备方法、应用、药物和药物递送系统 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003038049A2 (en) * | 2001-10-29 | 2003-05-08 | Renovis, Inc. | Method for isolating cell-type specific mrnas |
| US9217155B2 (en) * | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
| US9434928B2 (en) * | 2011-11-23 | 2016-09-06 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| BR112014020325A2 (pt) * | 2012-02-17 | 2017-08-08 | Childrens Hospital Philadelphia | composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos |
| EP3405215B1 (en) * | 2016-01-19 | 2022-06-15 | The Regents of the University of California | Methods for the treatment of danon disease and other disorders of autophagy |
| CA3011939A1 (en) * | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| WO2019028273A1 (en) * | 2017-08-02 | 2019-02-07 | Dna2.0, Inc. Dba Atum | DNA VECTORS AND ELEMENTS FOR SUSTAINED GENE EXPRESSION IN EUKARYOTIC CELLS |
| EP3820537A4 (en) * | 2018-07-12 | 2022-04-13 | Spacecraft Seven, LLC | GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE |
| WO2020033842A1 (en) * | 2018-08-10 | 2020-02-13 | Regenxbio Inc. | Scalable method for recombinant aav production |
-
2020
- 2020-02-12 US US17/430,107 patent/US20220143215A1/en active Pending
- 2020-02-12 BR BR112021015751A patent/BR112021015751A2/pt unknown
- 2020-02-12 CN CN202510460177.8A patent/CN120324641A/zh active Pending
- 2020-02-12 KR KR1020217022811A patent/KR20210125999A/ko active Pending
- 2020-02-12 CN CN202080011825.7A patent/CN113508130A/zh active Pending
- 2020-02-12 MX MX2021009696A patent/MX2021009696A/es unknown
- 2020-02-12 WO PCT/US2020/017987 patent/WO2020167996A1/en not_active Ceased
- 2020-02-12 JP JP2021546891A patent/JP2022520232A/ja active Pending
- 2020-02-12 AU AU2020221842A patent/AU2020221842A1/en not_active Abandoned
- 2020-02-12 CA CA3128514A patent/CA3128514A1/en active Pending
- 2020-02-12 SG SG11202107744SA patent/SG11202107744SA/en unknown
- 2020-02-12 EP EP20754942.9A patent/EP3924371A4/en active Pending
-
2021
- 2021-07-29 IL IL285238A patent/IL285238A/en unknown
-
2023
- 2023-03-01 AU AU2023201237A patent/AU2023201237B2/en active Active
-
2025
- 2025-01-20 JP JP2025007633A patent/JP2025063228A/ja active Pending
- 2025-07-09 AU AU2025205318A patent/AU2025205318A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531752A5 (enExample) | ||
| AU2023201237B2 (en) | Gene therapy vectors for treatment of Danon Disease | |
| CN111902539B (zh) | 杂合调控元件 | |
| JP2026050416A (ja) | ダノン病およびオートファジーの他の障害の治療のための方法 | |
| JP2024523707A5 (enExample) | ||
| JP7654562B2 (ja) | 線維芽細胞増殖因子２３関連低リン血症性疾患の遺伝子療法 | |
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| JP2021520811A (ja) | ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックａａｖベクターならびにその使用 | |
| KR20240118855A (ko) | 바이러스 벡터로 bag-3 관련 심근병증을 치료하는 방법 및 조성물 | |
| JP2024545186A (ja) | ウイルスベクターによるｍｙｂｐｃ３関連肥大型心筋症を処置するための方法および組成物 | |
| JP2024509792A (ja) | ファブリー病の治療のための組成物及び方法 | |
| JP7301860B2 (ja) | コア－シェル構造のマイクロ粒子を有効成分として含む成長因子遺伝子発現増加用組成物 | |
| KR20230029624A (ko) | 유전자 치료를 위한 글루코스-6-포스파타제(G6Pase-a)를 코딩하는 벡터 | |
| JP2022530359A5 (enExample) | ||
| JP2022530264A5 (enExample) | ||
| RU2024118293A (ru) | Векторы для генной терапии для лечения болезни данона | |
| RU2822925C2 (ru) | Векторы для генной терапии для лечения болезни данона | |
| JP2022514271A5 (enExample) | ||
| RU2021121516A (ru) | Векторы для генной терапии для лечения болезни данона | |
| RU2023129510A (ru) | Геннотерапевтические векторы для лечения болезни данона | |
| US11390854B2 (en) | Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof | |
| WO2025096910A1 (en) | Cpg-free codon-optimized human microdystrophin for duchenne muscular dystrophy gene therapy | |
| WO2025253097A1 (en) | Proteins with cardiopreservation activity | |
| CN116376921A (zh) | 一种用于治疗糖尿病的aav载体及其用途 | |
| RU2021103332A (ru) | Геннотерапевтические векторы для лечения болезни данона |